2-Fluoro-N-methyl-5-nitro-benzenesulfonamide, 95.0%, 1g

1-Boc-6-Methyl-1,4-diazepane, 95.0%, 100mg

8-AZASPIRO[4.5]DECAN-2-YLMETHYL ACETATE, 95.0%, 250mg

6-bromo-2-(trifluoromethyl)-1H,4H-pyrido[2,3-d]pyrimidin-4-one, 95%, 250mg

1-(Benzo[d][1,3]dioxol-5-yl)cyclobutane-1-carbonitrile, 98%, 5g

Bis(2-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)phenyl)amine, 97%, 1g

Naftaleno, mínimo 99%, para síntesis, 500 g, envase de plástico.

(R)-Methyl 2-amino-3-(4-bromophenyl)propanoate hydrochloride, 98%, 25g

6-Morpholinohexanoic acid, 97%, 100mg

(R)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine>97.0%(T)5g

3-Fluoro-4-(p-tolyloxy)aniline, 98%, 1g

1-(4-Bromobenzoyl)-4-methylpiperidine, 1g

3-(2-bromophenyl)-1-ethylpiperazine dihydrochloride, 95.0%, 250mg